Cargando…
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy
The development of biomarkers for autoimmune diseases has been hampered by a lack of understanding of disease etiopathogenesis and of the mechanisms underlying the induction and maintenance of inflammation, which involves complex activation dynamics of diverse cell types. The heterogeneous nature an...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436107/ https://www.ncbi.nlm.nih.gov/pubmed/25981462 http://dx.doi.org/10.1186/s13075-015-0644-z |